Functional assays further demonstrated that the prometastatic effects of POLR3G were mediated through this pathway, both in vitro and in vivo, establishing POLR3G as a critical effector of EMT and metastasis in bladder cancer [57]. Here, POLR3G is linked to urinary bladder carcinoma.